RSK2 and its binding partners: an emerging signaling node in cancers

Hye Suk Lee1,2,3, Sung-Jun Cho4, Han Chang Kang2,3

  • 1BK21-4th, College of Pharmacy, The Catholic University of Korea, 43, Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Insights

Ribosomal S6 Kinase 2 (RSK2) is a key signaling node in cancer, modulating cell proliferation, transformation, and immune responses. Understanding its complex network is crucial for developing effective anticancer drugs and avoiding side effects.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Mitogen-activated protein kinase (MAPK) pathways are critical in cancer development and therapeutic agent discovery.
  • Ribosomal S6 Kinase 2 (RSK2), downstream of ERKs, has been understudied in human diseases except for Coffin-Lowry syndrome.
  • RSK2's role in cancer signaling and its potential as a therapeutic target are gaining attention.

Purpose of the Study:

  • To elucidate the comprehensive role of RSK2 in cancer development.
  • To detail RSK2's binding partners, signaling network, and crosstalk.
  • To establish a new paradigm for RSK2 as a central signaling node.

Main Methods:

  • Extensive laboratory research over 25 years.
  • Elucidation of RSK2 binding partners.
  • Analysis of RSK2's signaling network and crosstalk.

Main Results:

  • RSK2 acts as a signaling node regulating diverse cellular processes.
  • Identified RSK2's modulation of cell proliferation, transformation, and cell cycle.
  • Demonstrated RSK2's role in chromatin remodeling, immune response, and inflammation.

Conclusions:

  • RSK2 is an emerging and important target for anticancer drug development.
  • A deeper understanding of RSK2's mechanism and signaling network is essential to avoid adverse effects of inhibitors.
  • RSK2's multifaceted role highlights its significance in cancer biology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
11.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.6K